| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study
|
Shash, Dalia
|
|
2016
|
12 |
5 |
p. 604-613
10 p.
|
article
|
| 2 |
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy
|
Hendrix, James A.
|
|
2016
|
12 |
5 |
p. 623-630
8 p.
|
article
|
| 3 |
Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
|
Weninger, Stacie
|
|
2016
|
12 |
5 |
p. 631-632
2 p.
|
article
|
| 4 |
Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
|
Llorens, Franc
|
|
2016
|
12 |
5 |
p. 577-589
13 p.
|
article
|
| 5 |
Contents
|
|
|
2016
|
12 |
5 |
p. A1-A2
nvt p.
|
article
|
| 6 |
Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease
|
Zhang, Cheng
|
|
2016
|
12 |
5 |
p. 527-537
11 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2016
|
12 |
5 |
p. A3-
1 p.
|
article
|
| 8 |
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit
|
Molinuevo, José L.
|
|
2016
|
12 |
5 |
p. 614-622
9 p.
|
article
|
| 9 |
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials
|
Thomas, Ronald G.
|
|
2016
|
12 |
5 |
p. 598-603
6 p.
|
article
|
| 10 |
Medical and Scientific Advisory Council
|
|
|
2016
|
12 |
5 |
p. A4-
1 p.
|
article
|
| 11 |
Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease
|
Podlesniy, Petar
|
|
2016
|
12 |
5 |
p. 546-555
10 p.
|
article
|
| 12 |
Motoric cognitive risk syndrome and risk of mortality in older adults
|
Ayers, Emmeline
|
|
2016
|
12 |
5 |
p. 556-564
9 p.
|
article
|
| 13 |
Subscriber Information
|
|
|
2016
|
12 |
5 |
p. A5-
1 p.
|
article
|
| 14 |
Surgery is associated with ventricular enlargement as well as cognitive and functional decline
|
Schenning, Katie J.
|
|
2016
|
12 |
5 |
p. 590-597
8 p.
|
article
|
| 15 |
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
|
Bittner, Tobias
|
|
2016
|
12 |
5 |
p. 517-526
10 p.
|
article
|
| 16 |
The pattern of amyloid accumulation in the brains of adults with Down syndrome
|
Annus, Tiina
|
|
2016
|
12 |
5 |
p. 538-545
8 p.
|
article
|
| 17 |
Validating Alzheimer's disease micro RNAs using next-generation sequencing
|
Keller, Andreas
|
|
2016
|
12 |
5 |
p. 565-576
12 p.
|
article
|
Journal description